학술논문
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Document Type
Article
Author
Source
In: Nature Communications . (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723